Intrinsiqq
Anixa Biosciences Inc. logo

Anixa Biosciences Inc. Financials

ANIX

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 17 available years
Income Statement
TTM
OCT 2025
OCT 2024
OCT 2023
OCT 2022
OCT 2021
Revenues
Revenue$1–$0$0–$1
Cost of Revenue$0$0$0$0$0$0
Gross Profit$1–$0$0–$0
General & Administrative$7$7$7$6$7$7
Research & Development$7$5$6$5$7$6
Total Operating Expenses$14$12$14$11$14$14
Operating Income-$14-$12-$14-$11-$14-$13
Minority Interest-$0-$0-$0-$0-$0-$0
Net Income
Net Income-$14-$11-$13-$10-$14-$13
Per Share Data
Revenue Per Share$0.02–$0.01$0.01–$0.02
EPS (Basic)-$0.46-$0.34-$0.39-$0.32$0.45-$0.45
EPS (Diluted)-$0.45-$0.34-$0.39-$0.32$0.45-$0.45
Weighted Avg Shares (Basic)30,93032,45431,89830,98030,37428.6M
Weighted Avg Shares (Diluted)30,93032,45431,89830,98030.4M28.6M
Shares Outstanding30.9M32.5M31.9M31.0M30.4M28.6M

Anixa Biosciences (ANIX) financials: revenue, profit and margins

Anixa Biosciences (ANIX) generated about n/a in revenue and -$10 million in net income over the trailing twelve months, growing at roughly -10.3% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Anixa Biosciences profitable?+

Anixa Biosciences reported about -$10 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How fast is Anixa Biosciences growing?+

Anixa Biosciences's revenue has compounded at roughly -10.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ANIX's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 9 Sept 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 10 Sept 2026. How this is calculated.

Fiscal year ends Oct.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ANIX

CompareIntrinsic value
LIPOLipella Pharmaceuticals Inc.
$0.00+0.00%25
CARMCarisma Therapeutics Inc.
$0.00+0.00%60
SLNOSoleno Therapeutics Inc
No recent price25
OPKOpko Health Inc.
$1.57-2.48%28
IBIOiBio, Inc.
$0.80+0.01%10
LFVNLifeVantage Corporation
$4.15-15.13%68
PAHCPhibro Animal Health Corporation
$33.29-2.32%57

Held by ETFs

ANIX is in 1 US ETF. The largest of them, with ANIX's weight in each:

Spot a number that looks wrong? Check it in ANIX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ANIX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.